Curaleaf Holdings Q2 2024 GAAP EPS $(0.06), Inline, Sales $342.286M Miss $344.912M Estimate
Portfolio Pulse from Benzinga Newsdesk
Curaleaf Holdings reported Q2 2024 GAAP EPS of $(0.06), meeting analyst expectations, but missed sales estimates with $342.286M, a slight increase from last year's $338.580M.
August 07, 2024 | 9:28 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Curaleaf Holdings reported Q2 2024 GAAP EPS of $(0.06), meeting analyst expectations. However, sales of $342.286M missed the $344.912M estimate by 0.76%, though they increased 1.09% year-over-year.
The earnings per share met expectations, which is neutral news. The slight miss in sales estimates and the small year-over-year increase in sales suggest a mixed impact, leading to a neutral short-term price direction.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100